Area of research
Pulmonary and Respiratory Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Cancer Genomics and Diagnostics, and MRI in cancer diagnosis.
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth
<scp>ST6GAL1</scp>‐mediated aberrant sialylation promotes prostate cancer progression
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates
Additional file 1 of The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates
Additional file 8 of The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates
Additional file 6 of The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates
Additional file 3 of The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates
Additional file 5 of The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates
Additional file 7 of The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates
Additional file 4 of The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates
Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer: A Large Cohort Study
PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer
A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI‐characterized prostates
PD60-02 DISCOVERY AND VALIDATION OF A NOVEL FLUID BIOMARKER FOR THE DIAGNOSIS AND RISK STRATIFICATION OF PROSTATE CANCER
DESNT: A Poor Prognosis Category of Human Prostate Cancer
Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data
Corrigendum to “Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study” [EBioMedicine 2 (9) (2015) 1133–1144]
Mutational signatures of ionizing radiation in second malignancies
<i>HNF1B</i> variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer
The evolutionary history of lethal metastatic prostate cancer
Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study
The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer
HES5 silencing is an early and recurrent change in prostate tumourigenesis
Abstract 956: The evolutionary history of lethal metastatic prostate cancer
Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer
Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes
Conditions Associated with Circulating Tumor-Associated Folate Receptor 1 Protein in Healthy Men and Women